Effect of increasing initial implant dosage on feedlot performance and carcass characteristics of long-fed steer and heifer calves 1 1A contribution of the University of Nebraska Agricultural Research Division, supported in part by funds provided through the Hatch Act. , 2 2Funding provided by Merck Animal Health (De Soto, KS). 3Adams Land and Cattle Co, Broken Bow, NE 68822.

F. Henry Hilscher, M. N. Streeter, Kyle J. Vander Pol, Bill Dicke, Robert J. Cooper, D. J. Jordon, Tony Scott, A. R. Vogstad, Robert E. Peterson, Brandon E. Depenbusch,

The Professional Animal Scientist · 2016 · 12 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

Three experiments evaluated initial implant strategies for finishing cattle. In Exp. 1, heifers (n = 1,405; initial BW = 282 kg) were given (1) Revalor-IH followed by Revalor-200 (REV-IH/200), (2) Revalor-H followed by Revalor-200 (REV-H/200), or (3) Revalor-200 followed by Revalor-200 (REV-200/200). Intake, ADG, and G:F were not affected (P ≥ 0.14) by implant strategies, nor were HCW and LM area (P ≥ 0.16). Percent USDA Choice was greater (P < 0.01) for Rev-IH/200 compared with Rev-H/200 and Rev-200/200. Experiment 2 used steers (n = 1,858; initial BW = 250 kg) given (1) Revalor-IS reimplanted with Revalor-200 (Rev-IS/200), (2) Revalor-XS followed by Revalor-IS (Rev-XS/IS), (3) Revalor-XS followed by Revalor-S (Rev-XS/S), or (4) Revalor-XS followed by Revalor-200 (Rev-XS/200). Implanting strategies did not affect (P ≥ 0.32) DMI or G:F. Carcass traits were not different (P ≥ 0.18) among treatments, except steers implanted with Rev-XS/200 had greater (P < 0.01) LM area. In Exp. 3, steers (n = 1,408; initial BW = 305 kg) were given (1) Rev-IS/200, (2) Rev-200/200, or (3) Rev-XS/200. Gain and G:F did not differ (P ≥ 0.36) among the 3 implant strategies, nor did HCW or marbling score (P ≥ 0.15). Steers given Rev-XS/200 had greater (P < 0.01) LM area and decreased (P ≤ 0.05) 12th-rib fat and YG compared with Rev-200/200 and Rev-IS/200. Using Rev-200/200 and Rev-XS/200 increased (P = 0.03) USDA Select compared with Rev-IS/200. Using greater-initial-dose implant strategies may not affect ADG or G:F but appears to increase leanness.

References

11